The Food and Drug Administration awarded a purchase order to Thinktrends, LLC for $89,650.20 on September 30, 2026, to acquire Think Trends Software licenses for adverse event document processing. Performance is located in Silver Spring, Maryland. The software is an agentic AI and document intelligence platform that automates intake, classification, optical character recognition, data extraction, validation, and routing of adverse event documents across seven FDA Centers—including the Center for Drug Evaluation and Research, Center for Biologics, Center for Devices and Radiological Health, Center for Tobacco Products, Center for Veterinary Medicine (Drug and Food), and Office of Human Foods Programs—with human-in-the-loop quality control and FOIA-compliant redaction. The order covers a Base Year period ending September 29, 2027. The procurement was conducted under FAR Part 13 as a brand name or equal acquisition for commercial items, full and open competition, with quotation due September 24, 2026.